In addition, CBD can reduce inducible nitric oxide synthase (iNOS) expression and nitric oxide (NO) production via CB1 activation [14], thereby modulating the inflammatory tumor microenvironment and potentially contributing to the cytotoxic and pro-apoptotic effects observed in the present study [13]. The gene discussed is CNR1; the disease is neoplasm.